June 2, 2008	BIOLASE to Present at Upcoming Investment Conference in New York City.
May 7, 2008	BIOLASE Reports 26% Year-Over-Year Sales Increase & Breakeven Net Income for the First Quarter of 2008.
May 1, 2008	BIOLASE Conference Call: 2008 First Quarter.
April 30, 2008	BIOLASE Names David M. Mulder Chief Financial Officer.
April 10, 2008	BIOLASE Announces Global Launch of Endolasetm RFT Root Canal Therapy System for Waterlase® MD Laser Systems.
March 19, 2008	BIOLASE Announces FDA 510(K) Clearance of its Waterlase® & Waterlase® MD Laser Systems for Root Canal Disinfection.
March 11, 2008	BIOLASE Reports Fourth Quarter & Full Year 2007 Results.
March 7, 2008	BIOLASE & Henry Schein Renew Exclusive North American Distribution Agreement.
February 7, 2008	BIOLASE Announces FDA 510(k) Clearance of its Waterlase® MD Laser System for Dermatology.
February 1, 2008	BIOLASE Names Fredrick M. Cappallo Interim Chief Financial Officer.
January 7, 2008	BIOLASE Announces Preliminary Fourth Quarter Revenue.
January 7, 2008	BIOLASE Names Healthcare Veteran Jake St. Philip Chief Executive Officer.
January 3, 2008	BIOLASE to Present at the Needham Growth Stock Conference in New York City.

spacertext